Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 25: The CARUSO Trial
Author(s): Tiziana Claudia Aranzulla Added: 3 months ago
ESC Congress 2025 - Evolocumab on top of lipid lowering therapy(LLT) reduced adverse vascular events at 12 months.Dr Tiziana Claudia Aranzulla (Mauriziano Umberto Hospital, Turin, IT) joins us to discuss findings from CARUSO (NCT04730973). The trial aimed to assess the efficacy of evolocumab with traditional LLT compared to traditional LTT alone in the stabilisation and regression of carotid… View more

Intervention

Prevention & Chronic Conditions
AI-based OCT Analysis from the BIOMAG-I FIH trial
Author(s): Hector M Garcia-Garcia Added: 1 year ago
In this interview, Prof Garcia-Garcia explains the methodology and findings of the AI-based OCT analysis and how this could impact practice in the future. View more

Intervention
Ramzi Y J Khamis
Job title: Professor of Cardiology, Wu Family Endowed Chair of Cardiology, Consultant Interventional Cardiologist
Prof Ramzi Y. J. Khamis is the Wu Family Endowed Chair of Cardiology at Imperial College London and Consultant Interventional Cardiologist at Imperial College Healthcare NHS Trust, where he leads the High-Risk Atherosclerosis and Cardio-Immune Clinic. He previously served as Clinical Director of Cardiology and Cardiothoracic Surgery at the Trust.His clinical expertise lies in interventional… View more
A Preferred Substrate-based Nomenclature in Myocardial Ischaemic Syndromes
Author(s): William E Boden , Juan Carlos Kaski , C Noel Bairey Merz , et al Added: 7 months ago

MI/ACS
View from the Thoraxcenter: What's Hot at ACC.24?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more

Anticoagulation

Cardiovascular Renal Metabolic
Lorenzo Azzalini headshot
Job title: Director of Interventional Cardiology Research and Associate Professor of Medicine
Dr. Azzalini is the Director of Interventional Cardiology Research and Associate Professor of Medicine at University of Washington, in Seattle, WA.He graduated magna cum laude from University of Padua in Italy in 2006. He subsequently completed cardiology training, a master’s degree in research methodology and a PhD in medicine at the Autonomous University of Barcelona in Spain. He completed two… View more
Confirm 2
Author(s): Alexander van Rosendael Added: 3 months ago
In this short interview, recorded at ESC 2025 (Madrid, ES) Dr Alexander R van Rosendael (Leiden University Medical Center, Leiden, NL) discusses data from the CONFIRM 2 registry, a large-scale study of clinically indicated coronary CT angiography incorporating automated, AI-guided quantification of atherosclerotic plaque. Building on prior visual-assessment registries, CONFIRM 2 applies whole… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Renu Virmani
Research Area(s) / Expertise: Job title: President and Medical Director
Personal History Dr Renu Virmani was born in 1943 in Pakistan. Her father was an industrialist of Delhi and Amritsar, India.2 As the youngest girl in a family of ten children, Dr Virmani was always driven to stand out and excel. Her aunt, who was a neurologist, was instrumental in forging her ambitions to pursue medicine. “I admired her and she showed me that women can do whatever they want… View more
ACC.24 Late-breaking Science Preview
Added: 1 year ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more

Anticoagulation

Cardiovascular Renal Metabolic
Prasad Gunasekaran
Research Area(s) / Expertise:

Coronary Interventions

Structural Intervention

 Job title: Interventional Cardiologist
Dr Prasad Gunasekaran is an interventional cardiologist with a focus on transcatheter structural heart interventions from Mercy Heart Hospital, Springfield, MO. He holds a special interest in intracoronary imaging with IVUS/OCT and vulnerable coronary plaques. His clinical practice involves use of intracardiac echo (ICE) for structural heart interventions and low-contrast precision percutaneous… View more